News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Industry News FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems July 07, 2015
News Industry News Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial July 07, 2015
News Daily News Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR Yael L. Maxwell July 06, 2015
News Daily News Poor Mobility Strongly Predicts Mortality in TAVR Patients Yael L. Maxwell July 06, 2015
News Industry News Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial July 06, 2015